March 30, 2017 / 5:15 AM / 23 days ago

BRIEF-Vaxxel Acquires Transgene's DuckCelt-T17 Cell Line

May 4 (Reuters) - TRANSGENE SA:

* VAXXEL ACQUIRES TRANSGENE’S DUCKCELT®-T17 CELL LINE TO DEVELOP INDUSTRIAL-SCALE VACCINES AGAINST RESPIRATORY VIRUSES

* TRANSGENE BECOMES A SHAREHOLDER OF VAXXEL. DUCKCELT®-T17, INITIALLY DEVELOPED AND PATENTED BY TRANSGENE, IS AN AVIAN CELL LINE GROWN IN SUSPENSION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below